Is lenvatinib/lenvatinib available in capsules?

Lenvatinib is an oral medication available in capsule form. This drug is a targeted therapy drug commonly used to treat thyroid cancer, renal cell cancer, hepatocellular carcinoma, endometrial cancer, etc. Lenvatinib capsules contain the active ingredient Lenvatinib, which works by inhibiting angiogenesis and tumor growth. Lenvatinib capsules for oral administration contain 4 mg or 10 mg of lenvatinib, equivalent to 4.90 mg or 12.25 mg of lenvatinib mesylate, respectively.

Lenvatinib is a targeted therapy. It is a multi-receptor tyrosine kinase inhibitor that targets certain proteins on cancer cells, causing the cells to grow and multiply. It selectively inhibits the activity of VEGFR, FGFR, RET, KIT and PDGFR. Lenvatinib is thought to block the signals that cells (cancer and normal cells) use to survive and reproduce. It is thought to block signals that help blood vessels grow. Blood vessels support tumor survival and growth. Because normal cells also have these proteins, they may be affected by treatments.

Lenvatinib capsules are used according to the patient's condition and doctor's advice, so you should consult a professional doctor before use. Usually, doctors will develop an appropriate dosage and usage plan based on factors such as the patient's weight, age, and condition. Follow your doctor's instructions and take the capsules for the prescribed time and dosage. Like other medicines, lenvatinib capsules may cause some adverse reactions. Common adverse reactions include nausea, vomiting, diarrhea, fatigue, loss of appetite, etc. If you experience any discomfort or unusual symptoms, please inform your doctor promptly.